Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

SHE:002412 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	88.29	128.02	51.13	145.41	90.31	103.56
Trading Asset Securities	329.66	244.12	203.87	135.82	49.24	-
Cash & Short-Term Investments	417.95	372.14	255	281.23	139.55	103.56
Cash Growth	52.64%	45.94%	-9.33%	101.52%	34.75%	-24.19%
Accounts Receivable	470.66	425.03	352.52	320.57	272.88	277.62
Other Receivables	17.28	17.89	8.34	11.96	1.86	35.15
Receivables	487.94	442.92	360.86	332.53	274.74	312.77
Inventory	212.21	222.88	231.12	246.62	103.37	84.43
Prepaid Expenses	-	-	3.8	-	1.23	2.71
Other Current Assets	80.94	85.23	45.28	5.03	16.51	23.99
Total Current Assets	1,199	1,123	896.07	865.4	535.41	527.46
Property, Plant & Equipment	480.47	489.16	515.61	439.45	470.75	485.63
Long-Term Investments	787.7	855.75	841.81	781.35	707.95	628.39
Goodwill	14.79	14.79	14.79	14.79	53.03	92.66
Other Intangible Assets	28.93	29.3	29.54	33.72	42.58	52.1
Long-Term Deferred Tax Assets	2.32	2.42	2.5	2.04	2.11	2.36
Long-Term Deferred Charges	14.5	14.41	15.13	15.71	16.42	17.14
Other Long-Term Assets	18.37	18.23	21.04	138.47	283.03	82.92
Total Assets	2,546	2,547	2,336	2,291	2,111	1,889
Accounts Payable	29.54	41.62	41.11	43.63	51.44	38.12
Accrued Expenses	17.96	39.74	62.58	66.83	48.31	30.54
Short-Term Debt	83.13	84.51	95.12	120.15	131.79	178
Current Income Taxes Payable	8	10.12	11.64	4.61	4.52	0.34
Current Unearned Revenue	1.55	2.72	6.48	7.02	1.71	3.52
Other Current Liabilities	187.45	139.61	138.51	138	113.33	22.91
Total Current Liabilities	327.63	318.32	355.42	380.24	351.11	273.43
Long-Term Unearned Revenue	24.1	24.54	16.81	15.03	16.22	18.12
Long-Term Deferred Tax Liabilities	1.08	1	1.22	1.54	1.66	2.37
Total Liabilities	352.81	343.85	373.46	396.81	368.99	293.92
Common Stock	503.2	503.2	503.2	503.2	503.2	503.2
Additional Paid-In Capital	234.12	234.12	234.12	234.12	232.77	202.31
Retained Earnings	1,447	1,436	1,215	1,161	993.7	897.86
Comprehensive Income & Other	9.11	30.45	10.34	-4.5	12.63	-8.65
Total Common Equity	2,193	2,203	1,963	1,894	1,742	1,595
Shareholders' Equity	2,193	2,203	1,963	1,894	1,742	1,595
Total Liabilities & Equity	2,546	2,547	2,336	2,291	2,111	1,889
Total Debt	83.13	84.51	95.12	120.15	131.79	178
Net Cash (Debt)	334.82	287.63	159.88	161.08	7.76	-74.44
Net Cash Growth	87.37%	79.90%	-0.74%	1975.89%	-	-
Net Cash Per Share	0.67	0.57	0.32	0.32	0.02	-0.15
Filing Date Shares Outstanding	502.55	502.89	503.2	503.2	503.2	503.2
Total Common Shares Outstanding	502.55	502.89	503.2	503.2	503.2	503.2
Working Capital	871.41	804.85	540.65	485.17	184.3	254.03
Book Value Per Share	4.36	4.38	3.90	3.76	3.46	3.17
Tangible Book Value	2,150	2,159	1,919	1,846	1,647	1,450
Tangible Book Value Per Share	4.28	4.29	3.81	3.67	3.27	2.88
Buildings	-	-	644.48	531.89	533.67	499.4
Machinery	-	-	223.66	221.69	218.69	207.09
Construction In Progress	-	-	9.08	6.09	5.26	26.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.